Skip to main content
Caplight Logo









The Silverstein Foundation for Parkinson's with GBA

The Silverstein Foundation for Parkinson's with GBA

New York City, New Yorksilversteinfoundation.org

Overview

The Silverstein Foundation for Parkinson's with GBA is a non-profit foundation that invests in cutting-edge research to discover and accelerate new therapies for the treatment of Parkinson's Disease in glucocerebrosidase (GBA) mutation carriers.

Year Founded

2017

Portfolio Companies

2

Investments

The Silverstein Foundation for Parkinson's with GBA investments
CompanyDateStageLead
Lysoway TherapeuticsJan 2023GrantCo-investor
Acurex BiosciencesAug 2021GrantCo-investor
Acurex Biosciences-SeedCo-investor

Key People

Jonathan Silverstein

President and Co-Founder

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersNew York City, New York
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?